Login to Your Account



Renovo Cuts 100 Jobs

Shire Dumps Renovo's Scar Drug After Phase III Failure

By Nuala Moran


Friday, March 4, 2011
LONDON – Renovo plc is shutting up the shop, announcing plans to cut more than 100 of its 110 staff and halt all clinical development, after an analysis of the failed Phase III trial of its scar prevention treatment Juvista concluded the product is ineffective.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription